BioPharma Dive22m
Biohaven muscle drug misses goal of SMA study, but advances in obesity
The setback likely removes one competitor to an emerging spinal muscular atrophy medicine from Scholar Rock, but sets the ...
BioPharma Dive8h
Gene Silencing Technology Unlocks Rapid Weight Loss While Preserving Lean Mass and Preventing Weight Regain
Reduced Weight Regain: CCT-217 shows promise in preventing weight regain commonly observed after discontinuing incretin ...